Open Access

Live Q&A.

Topic: Chronic Heart Failure, Other
Sponsored by AstraZeneca


2 more presentations in this session

Welcome and introductions Optimising patient outcomes: A guide to the initiation of SGLT2 inhibitors from first-hand experience.

Speaker: Professor G. Fonarow (Los Angeles, US)


Considerations for therapy optimisation.

Speaker: Professor C. Lam (Singapore, SG)


Access the full session

SGLT2 inhibitors: optimising heart failure treatment

Speakers: Professor G. Fonarow, Professor C. Lam

About the event


Heart Failure 2021 Online Congress

29 June - 1 July 2021

Sessions Presentations

Related content

Open Access

Long-term outcomes in PAH: Optimised approach to achieve the best outcomes.

27 August 2021

Open Access

Welcome and objectives.

27 August 2021

ESC Premium Access

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

27 August 2021

This platform is supported by

logo Novo Nordisk